Royce & Associates LP Avanos Medical, Inc. Transaction History
Royce & Associates LP
- $9.35 Billion
- Q3 2025
A detailed history of Royce & Associates LP transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 32,221 shares of AVNS stock, worth $366,997. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,221Holding current value
$366,997% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AVNS
# of Institutions
301Shares Held
44.7MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY7.01MShares$79.9 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.71MShares$53.7 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.43MShares$39 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY2.5MShares$28.5 Million0.44% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.35MShares$26.8 Million0.01% of portfolio
About AVANOS MEDICAL, INC.
- Ticker AVNS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 46,487,000
- Market Cap $529M
- Description
- Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...